Evidence map›Paper›PMID 26303407›Full record

ArticleJournal of neurochemistry2015

Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.

Liangliang Zhao, Majda Hadziahmetovic, Chenguang Wang, Xueying Xu, Ying Song, H A Jinnah, Jolanta Wodzinska, Jared Iacovelli, Natalie Wolkow, Predrag Krajacic and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The biology of mammalian multi-copper ferroxidases.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. International journal of molecular sciences · 2021
    Article
  9. Iron Homeostasis and Metabolism: Two Sides of a Coin.Advances in experimental medicine and biology · 2021
    Review
  10. Retinal Degeneration and Alzheimer's Disease: An Evolving Link.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Haemochromatosis.Nature reviews. Disease primers · 2018
    Review
  17. Article
  18. Animal Models of Tremor: Relevance to Human Tremor Disorders.Tremor and other hyperkinetic movements (New York, N.Y.) · 2018
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Liangliang ZhaoF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Majda HadziahmetovicF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Chenguang WangF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Xueying XuDepartment of Medicine, Sinai Hospital, Baltimore, Maryland, USA.
Ying SongF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
H A JinnahDepartments of Neurology, Human Genetics and Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Jolanta WodzinskaApoPharma Inc, Toronto, California, USA.
Jared IacovelliF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Natalie WolkowF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Predrag KrajacicF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alyssa Cwanger WeissbergerF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John ConnellyApoPharma Inc, Toronto, California, USA.
Michael SpinoApoPharma Inc, Toronto, California, USA.
Michael K LeeDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA.
James ConnorDepartment of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Benoit GiassonDepartment of Neuroscience, College of Medicine, University of Florida, Gainesville, Florida, USA.
Z Leah HarrisDepartment of Pediatrics, Northwestern University, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Joshua L DunaiefF.M Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Penn Presbyterian Medical Center · USUniversity of Pennsylvania · USDrexel University · USEmory University · USNorthwestern University · USPenn State Milton S. Hershey Medical Center · USSecond Affiliated Hospital of Jilin University · CNSinai Hospital · USUniversity of Florida · USUniversity of Minnesota · USUniversity of Toronto · CA

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Qi N Cui · 1985 to 2026
$19.5M
Retinal Iron Transport in Health and DiseaseR01EY015240 · NEI · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA L DUNAIEF · 2004 to 2026
$10.4M
NEI NIH HHS NIH EY015240NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY015240
6 · The paper itself

Abstract

Brain iron accumulates in several neurodegenerative diseases and can cause oxidative damage, but mechanisms of brain iron homeostasis are incompletely understood. Patients with mutations in the cellular iron-exporting ferroxidase ceruloplasmin (Cp) have brain iron accumulation causing neurodegeneration. Here, we assessed the brains of mice with combined mutation of Cp and its homolog hephaestin. Compared to single mutants, brain iron accumulation was accelerated in double mutants in the cerebellum, substantia nigra, and hippocampus. Iron accumulated within glia, while neurons were iron deficient. There was loss of both neurons and glia. Mice developed ataxia and tremor, and most died by 9 months. Treatment with the oral iron chelator deferiprone diminished brain iron levels, protected against neuron loss, and extended lifespan. Ferroxidases play important, partially overlapping roles in brain iron homeostasis by facilitating iron export from glia, making iron available to neurons. Above: Iron (Fe) normally moves from capillaries to glia to neurons. It is exported from the glia by ferroportin (Fpn) with ferroxidases ceruloplasmin (Cp) and/or Hephaestin (Heph). Below: In mice with mutation of Cp and Heph, iron accumulates in glia, while neurons have low iron levels. Both neurons and glia degenerate and mice become ataxic unless given an iron chelator.

Indexed as

Neurodegenerative DiseasesAnimalsBrainCeruloplasminDeferiproneDisease Models, AnimalIronIron Chelating AgentsMembrane ProteinsMiceMice, TransgenicMotor ActivityMuscle StrengthMutationMyelin Basic ProteinNerve Tissue ProteinsCeruloplasminDeferiproneHeph protein, mouseIronIron Chelating AgentsMbp protein, mouseMembrane ProteinsMyelin Basic ProteinNerve Tissue ProteinsPyridonesTyrosine 3-Monooxygenaseceruloplasmin/Hephaestindeferipronegliaironneurodegenerationoxidative stress

Identifiers

PMID26303407
PMCPMC4943332
OpenAlexW2123138049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.